Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Vascular Doppler Sonography in Decompensated Heart Failure
NCT02372292Completed
- Sponsor
- Ankara University
- Start
- Feb 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of furosemide in heart failure (HF) and cardiorenal syndrome (CRS) (2 arms), sponsored by Ankara University. Primary endpoint: Alterations in the renal arterial resistivity index at 4 weeks. Started Feb 2013; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT02372292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372292.